You can now mix and match COVID-19 booster shots
Americans eligible for COVID-19 booster shots no longer need to stick to one brand. Here’s why that’s a big deal.
FDA panel recommends COVID-19 vaccine for 5 to 11 year olds (Updated)
An FDA panel voted to authorize Pfizer’s COVID-19 vaccine for kids ages 5 to 11. Here’s what you need to know about it.
Ear sensor can monitor COVID-19 patients remotely
An ear sensor successfully alerted doctors to signs that COVID-19 patients isolating at home were getting worse and should be hospitalized.
Pill to treat COVID-19 cuts risk of hospitalization or death in half
A pill to treat COVID-19 that cut hospitalizations and deaths in half could become the first oral medication against the disease.
Antiviral reduces COVID-19 hospitalizations by 87%
The FDA-approved antiviral drug remdesivir prevents high-risk people from ending up in the hospital, if given early.
FDA approves COVID-19 boosters for seniors, high-risk groups (Updated)
The FDA has expanded its authorization of COVID-19 boosters of Pfizer’s vaccine to include seniors and people in high-risk populations.
Pfizer says its COVID-19 vaccine works in kids
New trial results suggest Pfizer’s COVID-19 vaccine works in kids between the ages of 5 and 11, safely triggering a robust antibody response.
Moderna’s new vaccine targets COVID-19, the flu, and RSV
Moderna is developing a combination vaccine to protect against COVID-19, seasonal influenza, and respiratory syncytial virus.
Study: COVID-19 booster shots dramatically reduce infection risk
A large COVID-19 booster shot study in Israel found that a third dose significantly increased seniors’ protection against the coronavirus.